Browsing by Subject "Opioid epidemic"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Acute Cytotoxic Cerebellar Edema Subsequent to Fentanyl Patch Intoxication in an Infant
    (Hindawi, 2021-09-07) Haut, Lindsey N.; Radhakrishnan, Rupa; Lutfi, Riad; Kao, Louise W.; Ackerman, Laurie L.; Emergency Medicine, School of Medicine
    The opioid epidemic continues to have devastating consequences for children and families across the United States with rising prevalence of opioid use and abuse. Given the ease of access to these medications, accidental ingestion and overdose by children are becoming increasingly more common. The recognition of opioid-induced neurotoxicity and the associated life-threatening complication of acute cerebellar cytotoxic edema are crucial, as are the high morbidity and mortality without timely intervention. We discuss an infant with acute cytotoxic cerebellar edema following mucosal exposure to a transdermal fentanyl patch.
  • Thumbnail Image
    Item
    Revisiting patient-related barriers to cancer pain management in the context of the US opioid crisis
    (Wolters Kluwer, 2021) Kwekkeboom, Kristine; Serlin, Ronald C.; Ward, Sandra E.; LeBlanc, Thomas W.; Ogunseitan, Adeboye; Cleary, James; Medicine, School of Medicine
    Patient fear of addiction is a well-documented barrier to the use of analgesic medications for cancer pain control. Over the past 2 decades in the United States, an "opioid crisis" has arisen, accompanied by risk messages delivered through news outlets, public health education, and patient-provider communication. The purpose of this study was to determine if patient-related barriers to cancer pain management-specifically, fears of addiction-and related pain outcomes (pain severity, pain interference with daily life, and adequacy of pain management) have worsened over the last 20 years. A sample of 157 outpatients with active recurrent or active metastatic cancer completed the Barriers Questionnaire-II (BQ-II) and measures of pain and analgesic use. We identified 7 comparison studies published between 2002 and 2020 that reported patient-related barriers using the BQ-II. Significant linear relationships were found between later year of publication and greater fear of addiction (harmful effect subscale score, B = 0.0350, R2 = 0.0347, F1,637 = 23.19, P < 0.0001) and between year of publication and more pain management barriers overall (total BQ-II score, B = 0.039, R2 = 0.065, F1,923 = 73.79, P < 0.0001). Relationships between BQ-II scores (harmful effect and total) and pain outcomes did not change over time. Despite worsening in patient-related barriers, the proportion of patients with adequate vs inadequate analgesic use did not differ over time. Notably, 40% of participants reported inadequate analgesic use, a statistic that has not improved in 20 years. Additional research is necessary to clarify factors contributing to changing beliefs. Findings indicate a continuing need for clinical and possibly system/policy-level interventions to support adequate cancer pain management.